Medizinische Universität Graz - Research portal

Navigation/Search

Abstract: Endometrial cancer rates have risen over the last two decades, in some countries very significantly due to a combination of factors that includes an ageing population, increased obesity, and exposure to oestrogens.
With this burgeoning research agenda there is an urgent need to develop a specific quality of life measure for women with endometrial cancer that is sensitive to the impact of treatments so that their affect on quality of life can be assessed. In addition patients are increasingly encouraged to seek information about the impact of treatment on their quality of life so that they can make informed choices about their treatment and care.

Staff: Greimel, Elfriede Renate, Project Leader; Bjelic-Radisic, Vesna, Co-worker; Mautner, Eva, Co-worker

MUG Research Units: Department of Obstetrics and Gynaecology; Division of General Gynaecology

Project partners: Christie Hospital NHS Trust, United Kingdom; Clinical Hospital Center Rijeka University Hospital, Gynaecology Dept., Croatia; Dept. of Gynecological Oncology Radiumhemmet/Karolinska University Hospital, Sweden; Dept of Gynecology/Medical University of Gdansk, Poland; East Kent Gynaecological Oncology Centre/Queen Elisabeth the Queen Mothers Hospital, United Kingdom; Federal University of Sao Paulo, Brazil; Gynaecological Research Unit, University College London, United Kingdom; Herlev University Hospital, Dept. of Gynaecology and Obstetrics, Denmark; Medical Center, Leiden University, Netherlands; Medizinische Universität Leipzig, Germany; National Taiwan University Hospital / College of Public Health, Taiwan; Royal Hospital for Women, Australia; Sahlgrenska University Hospital, Sweden

Funded by: European Organisation for Research and Treatment of Cancer (EORTC), Brüssel, Belgium